BioSpace News Archive

BioNova to Host the 20 th Annual Regional BioPort Conference to Highlight the Innovation and Growth Potential of Health and Life Sciences

Cerus Corporation (Nasdaq: CERS), a company solely dedicated to safeguarding the global blood supply, and the Transfusion Service of the Swiss Red Cross (Blutspende SRK Schweiz) announced today the tenth anniversary of the use of the INTERCEPT Blood System for its entire platelet supply in Switzerland.

AcelRx to receive up to approximately $55 million in combined up-front and sales-based milestone payments for DZUVEO licensing agreement

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the third-party, investigator-initiated Phase 2 HALT-D study evaluating the effectiveness of Mytesi (crofelemer) for symptomatic relief of diarrhea in HER2 positive breast cancer.

Preclinical results in a pancreatic cancer model show that MDNA109, delivered by an oncolytic adenovirus, induced superior anti-tumor response with tendency towards complete tumor regression, improved survival, and long-term immune memory effect

BurstIQ announced today that longtime partner FlowMetric Life Sciences, launched their novel vaccine immune response test, VaxEffect™.

Cue Health Inc. (“Cue Health” or “Cue”), a healthcare technology company, today announced it has received regulatory approval from The Central Drugs Standard Control Organisation (CDSCO) for the Cue COVID-19 Test for professional point-of-care use in India.

Shorla Pharma Limited, a specialty pharmaceutical company, has announced its arrival in the United States locating a base in Boston’s innovative Cambridge biotech cluster.

Curebase today announced that InBios successfully utilized Curebase’s virtual site solution to power clinical studies for its SCoV-2 Ag Detect™ Rapid Test, which was granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) on May 6, 2021.

ViaClean Technologies, LLC, a Philadelphia-based biotech company, jointly with its distributor and business development partner, Bizos Cavallo Enterprises LLC of Dallas, TX, and their partner,V-Clean Technologies S.A. of Athens, Greece, jointly announced the country of Greece’s approval for the use of BIOPROTECT™ RTU on porous and non-porous surfaces in the fight against SARS-CoV-2.